Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.
Key Details
- 1REDMOD is an AI radiomics model for detecting subtle texture changes indicative of stage 0 pancreatic ductal adenocarcinoma on CT.
- 2The model identified preclinical disease an average of 475 days before clinical diagnosis.
- 3In head-to-head comparison, REDMOD's sensitivity was nearly double that of expert radiologists (73% vs. 39%).
- 4Performance remained high (68% vs. 23%) for cancers detected over two years before diagnosis.
- 5The model showed strong generalisability in external cohorts (correctly identifying >81% and 87.5% of cases in independent datasets).
- 6Researchers caution further prospective validation and testing in high-risk patients are needed before clinical adoption.
Why It Matters
Ultra-early detection of pancreatic cancer could dramatically improve survival rates by enabling treatment before symptoms arise. AI models like REDMOD may soon provide radiologists with powerful new tools to catch deadly cancers in their most treatable phases.
Source
EurekAlert
Related News
•EurekAlert
Review Finds AI Model Architecture Key for Brain Tumor MRI Segmentation
A systematic review highlights that AI model architecture, more than data or imaging specifics, drives improved tumor segmentation in brain MRI scans.
•EurekAlert
Mount Sinai to Showcase AI Innovations in Lung and Sleep Imaging at ATS 2026
Mount Sinai experts will present new research on AI and imaging for lung nodules, sleep apnea, and cardiovascular risk at the ATS 2026 Conference.
•EurekAlert
AI Doctor Avatars Boost Cancer Patient Understanding Before Radiology Consults
Meeting an AI avatar doctor before consultations helps cancer patients understand treatment better and reduces stress.